AriBio Co., Ltd. and Fujirebio Diagnostics, Inc. partner to advance biomarker development for Alzheimer’s disease and neurodegeneration
Strategic partnership aims to accelerate biomarker development to improve the diagnosis of Alzheimer’s disease and and other neurological disorders